The store will not work correctly when cookies are disabled.
(-)-(2R)-1-Benzyl-4-butyl-2-methyl-1,4-diazepane
ID: ALA4063826
PubChem CID: 137636696
Max Phase: Preclinical
Molecular Formula: C17H28N2
Molecular Weight: 260.43
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCCCN1CCCN(Cc2ccccc2)[C@H](C)C1
Standard InChI: InChI=1S/C17H28N2/c1-3-4-11-18-12-8-13-19(16(2)14-18)15-17-9-6-5-7-10-17/h5-7,9-10,16H,3-4,8,11-15H2,1-2H3/t16-/m1/s1
Standard InChI Key: GUTQUDZTMHWKRE-MRXNPFEDSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
34.5020 -1.9176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2436 -1.5745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9821 -1.9372 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.3069 -2.7183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1588 -2.7379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8151 -3.3673 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.6374 -3.3732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9885 -4.1172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4546 -4.1007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6248 -1.4325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9096 -4.7796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5450 -5.5119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9992 -6.1903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8155 -6.1361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1754 -5.3978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7191 -4.7224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3833 -1.7367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0260 -1.2320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7844 -1.5363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
1 4 1 0
3 5 1 0
4 6 1 0
5 7 1 0
6 7 1 0
7 8 1 1
6 9 1 0
3 10 1 0
9 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
10 17 1 0
17 18 1 0
18 19 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 260.43 | Molecular Weight (Monoisotopic): 260.2252 | AlogP: 3.38 | #Rotatable Bonds: 5 |
Polar Surface Area: 6.48 | Molecular Species: BASE | HBA: 2 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.82 | CX LogP: 3.56 | CX LogD: 1.17 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.80 | Np Likeness Score: -1.20 |
References
1. Fanter L, Müller C, Schepmann D, Bracher F, Wünsch B.. (2017) Chiral-pool synthesis of 1,2,4-trisubstituted 1,4-diazepanes as novel σ1 receptor ligands., 25 (17): [PMID:28764962] [10.1016/j.bmc.2017.07.027] |